Work

A Placebo-Controlled Phase I Study of NVG-291 in Healthy Subjects, Targeting CNS Receptor Protein Tyrosine Phosphatase Sigma (PTPσ) (S8.009)

Year: 2022

Type: article

Study design: Clinical Trial

Source: Neurology

DOI: 10.1212/wnl.98.18_supplement.1679

Authors: Daniel Mikol, Betty Lawrence, Nana Collett, Judy Toews, Matvey Lukashev, Marc DePaul

Language: English

Topic: Protein Tyrosine Phosphatases

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389376114

FWCI:

Cites:

Cited by:

Related to: 10